Opportunity

SAM #BARDA-CBRN-07282026

BARDA Requests Information on Advanced Dermal Regeneration Solutions for Severe Burns and Trauma

Buyer

ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE

Posted

July 28, 2026

Respond By

August 28, 2026

Identifier

BARDA-CBRN-07282026

NAICS

339113, 541714, 325414, 541715

The Biomedical Advanced Research and Development Authority (BARDA), under the Department of Health and Human Services (HHS), is seeking information on advanced dermal regeneration substitutes for severe burns and traumatic injuries. - Government Buyer: - Department of Health and Human Services (HHS) - Office of the Assistant Secretary for Preparedness and Response (ASPR) - Biomedical Advanced Research and Development Authority (BARDA) - OEMs and Vendors: - No specific OEMs or vendors are mentioned in the request - Products/Services Requested: - Innovative medical countermeasure technologies for large-area skin loss due to thermal burns or traumatic injuries - Solutions should support: - Wound healing - Accelerated wound closure - Infection control - Functional tissue regeneration - Unique or Notable Requirements: - Technologies must be commercially available or near-commercial - Must be suitable for use in mass casualty incidents - Emphasis on products that can temporize wound healing and regenerate functional tissue - No specific part numbers, models, or quantities provided - This is a Request for Information (RFI) to identify potential solutions, not a solicitation for purchase

Description

This Notice is issued by the Biomedical Advanced Research and Development Authority (BARDA) to identify innovative medical countermeasure technologies capable of addressing large-area skin loss due to thermal burns or traumatic injuries in a mass casualty incident. This request is for information only and is intended to assess the current state of commercially available or near-commercial availability technologies that support temporizing wound healing, accelerated wound closure, infection control, and functional tissue regeneration.

View original listing